Top stories in hematology/oncology: FDA approves DNA-based assay, panel backs biosimilar for lymphoma


Among the most-read stories in hematology/oncology this week were reports that the FDA approved … that CAR T-cell therapy seemed cost-effective in treating patients with pediatric leukemia. – by Jan…

Read more